A Phase II Study of Advanced Colorectal Cancer Patients Treated with Combination 5-Fluorouracil Plus Leucovorin and Subcutaneous Interleukin-2 Plus Alpha Interferon

Phase Ii Study ◽

Interleukin 2 ◽

Alpha Interferon ◽

Phase II Study of Pulse 5-Fluoro-2′-Deoxyuridine and Leucovorin in Advanced Colorectal Cancer Patients Previously Treated with Chemotherapy

American Journal of Clinical Oncology ◽

10.1097/00000421-199204000-00004 ◽

1992 ◽

Vol 15 (2) ◽

pp. 115-118 ◽

Cited By ~ 1

Author(s):

John C. Marsh ◽

Henry J. Durivage ◽

Carol Davis ◽

Kyle OʼHollaren ◽

Dominick N. Pasquale ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Previously Treated ◽

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group

Annals of Oncology ◽

10.1023/a:1008342928408 ◽

2000 ◽

Vol 11 (8) ◽

pp. 1045-1052 ◽

Cited By ~ 29

Author(s):

E. Maiello ◽

V. Gebbia ◽

F. Giuliani ◽

G. Paoletti ◽

N. Gebbia ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Southern Italy ◽

Phase Ii Study ◽

Oncology Group ◽

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-006-0302-x ◽

2006 ◽

Vol 59 (5) ◽

pp. 613-620 ◽

Cited By ~ 14

Author(s):

Daniele Santini ◽

Bruno Vincenzi ◽

Gaia Schiavon ◽

Marisa Di Seri ◽

Vladimir Virzí ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Colorectal Cancer Patients ◽

Line Chemotherapy

A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6603095 ◽

2006 ◽

Vol 94 (9) ◽

pp. 1287-1292 ◽

Cited By ~ 32

Author(s):

M Mabro ◽

◽

P Artru ◽

T André ◽

M Flesch ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Oxaliplatin with Weekly Bolus 5-Fluorouracil and Leucovorin in Pretreated Advanced Colorectal Cancer Patients: A Phase II Study

Chemotherapy ◽

10.1159/000071144 ◽

2003 ◽

Vol 49 (4) ◽

pp. 194-199 ◽

Cited By ~ 11

Author(s):

Tsai-Shen Yang ◽

Jinn-Shium Chen ◽

Reiping Tang ◽

Jy-Ming Chiang ◽

Pau-Shiu Hsieh ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Weekly Bolus ◽

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6601382 ◽

2003 ◽

Vol 89 (10) ◽

pp. 1870-1875 ◽

Cited By ~ 17

Author(s):

C Garufi ◽

E Bria ◽

B Vanni ◽

A M R Zappalà ◽

I Sperduti ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

British Journal of Cancer ◽

10.1038/sj.bjc.6604121 ◽

2007 ◽

Vol 98 (1) ◽

pp. 71-76 ◽

Cited By ~ 28

Author(s):

S Cascinu ◽

R Berardi ◽

S Salvagni ◽

G D Beretta ◽

V Catalano ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicentre Phase ◽

Colorectal Cancer Patients ◽

First Line Treatment

Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2005.03.012 ◽

2006 ◽

Vol 42 (5) ◽

pp. 608-616 ◽

Cited By ~ 13

Author(s):

Carlo Garufi ◽

Barbara Vanni ◽

Anna Maria Aschelter ◽

Albina Rita Zappalà ◽

Emilio Bria ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.2015.982099 ◽

2014 ◽

Vol 15 (1) ◽

pp. 101-110

Author(s):

Jacopo Giuliani ◽

Anna Mercanti ◽

Silvia Muraro ◽

Anna Rita Trolese ◽

Emilia Durante ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liver Resections ◽

Colorectal Cancer Patients ◽

Phase Ii And Iii

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial

Annals of Oncology ◽

10.1093/annonc/mdz082 ◽

2019 ◽

Vol 30 (5) ◽

pp. 796-803 ◽

Cited By ~ 5

Author(s):

C. Santos ◽

D. Azuara ◽

J.M. Viéitez ◽

D. Páez ◽

E. Falcó ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

High Sensitivity ◽